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Abstract. The incidence of rectal neuroendocrine tumor
(NET), which is often diagnosed during routine surveillance
endoscopy, is increasing. The majority of these tumors are
small and asymptomatic, possessing benign features with
favorable prognoses. At present, small rectal NETs without
high‑risk factors are typically treated by local resection,
including endoscopic mucosal resection, endoscopic submucosal dissection, or transanal endoscopic microsurgery,
with or without additional imaging follow‑up by abdominal
computed tomography or magnetic resonance imaging. The
present study, however, describes a case of a small rectal
NET without any known risk factors, which was accompanied by substantial locoregional lymph node metastasis,
underscoring the importance of imaging studies for rectal
NETs.
Introduction
The incidence and prevalence of gastroenteropancreatic
neuroendocrine tumors (NETs) have been increasing globally;
the crude incidence is estimated to be 5.25/100000/year
and the prevalence to be 35/100000/year according to the
2012 European Society of Medical Oncology guidelines (1),
and rectal NETs are the most common type of gastroenteropancreatic NET in Asia, according to the epidemiological reports
in 2010 and 2012 (2,3). Among rectal NETs, ~50% of cases are
asymptomatic and are identified incidentally during routine
surveillance colonoscopy as sub‑epithelial tumors (4). Little
is known with regard to the risk factors of rectal NETs due to
the lack of epidemiological studies. However, a small number
of studies have proposed potential risk factors for rectal NETs,
including sex, age, ethnicity, general family history of cancer
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and alcohol consumption (5‑7). Men exhibited a higher risk
of rectal NETs compared with women in a study of an Asian
population, whereas female predominance was revealed in
populations from the USA or Sweden, indicating possible
differences in susceptibility to rectal NETs according to the
ethnic group (5‑7). In addition, non‑Caucasian populations
(those of Hispanic, African or Asian descent) exhibited a higher
prevalence of rectal NETs compared with Caucasian populations (6). Young age (<50 or ≤60) was also associated with an
increased risk of developing rectal NET (5,6). Furthermore,
there are conflicting data regarding alcohol and smoking exposure, but a previous study suggested alcohol consumption as
an important risk factor (5). However, due to the lack of large
epidemiological studies, the strength of these associations is
not fully known, and additional studies to determine the risks
associated with rectal NETs are required.
The majority of rectal NETs are small and superficial,
with indolent characteristics (8). Traditionally, tumor size
and depth of invasion are considered important risk factors
for metastasis. Due to their low risk of metastasis, the standard treatment modality for small (<2 cm) and superficial
(confined within submucosa) rectal NETs is local resection,
including endoscopic mucosal resection (EMR), cap‑assisted
EMR (C‑EMR), endoscopic submucosal dissection (ESD),
and transanal endoscopic microsurgery (4,9). However,
several studies have described the occurrence of lymph node
metastasis from these small tumors, resulting in disagreement
over the optimal treatment modality (local resection vs.
radical resection) (10). Some authors have recommended a
stratified approach outlined by the study of Fahy et al (11),
which assigns a score after considering risk factors for
poor outcome, e.g. distant metastasis, recurrent disease
and reduced recurrence‑free and diseases‑specific survival.
This also takes into consideration tumor size, mitotic rate,
deep invasion and lymphovascular invasion, which can be
measured by an endoscopic biopsy sample or endoscopic
excision (e.g., EMR or ESD) (11). In case of low risk tumors
(for poor outcome), endoscopic or transanal excision may be
acceptable; however, in cases of high‑risk tumors, radical
resection should be considered (11).
The present study describes the case of a small rectal NET,
without any known risk factors, but with substantial locoregional lymph node metastasis.
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Figure 1. Colonoscopic image of terminal ileum and distal rectum. (A) Terminal ileitis with edematous hyperemic mucosa. (B) Oval‑shaped subepithelial
tumor with normal surface mucosa and smooth margins in the distal rectum.

Figure 2. Transrectal endoscopic ultrasound revealing a 1.5‑cm, ovoid,
hypoechoic, subepithelial lesion with smooth margins originating from the
second layer, which corresponds to deep mucosal layer.

Case report
A 25‑year‑old man presented to Kangwon National University
Hospital (Chuncheon, South Korea) in March 2017, subsequent
to suffering from acute diarrhea, fever, vomiting and abdominal pain for 3 days, in addition to 2 years of chronic anal
bleeding. A physical examination revealed mild abdominal
tenderness in his right lower quadrant. A digital rectal examination indicated a 1‑cm, hard, smooth‑surfaced and palpable
mass in the distal rectum. A sigmoidoscopy was performed to
evaluate the palpable distal rectal lesion; the terminal ileum
was reached following the removal of fecal material, which
revealed edematous hyperemic mucosa of the terminal ileum
and an oval‑shaped subepithelial tumor (SET) with normal
surface mucosa in the distal rectum. The colonic mucosa was
otherwise intact, without inflammation or bleeding (Fig. 1).
A transrectal endoscopic ultrasound (EUS) for distal rectal
SET revealed a 1.5‑cm, ovoid, hypoechoic lesion originating

from the second layer, which corresponded to the deep mucosa
(Fig. 2).
The most probable diagnosis was a rectal carcinoid tumor
combined with acute gastroenteritis, and it was decided to
pursue a histopathological diagnosis by endoscopic or surgical
resection following resolution of the acute enteritis. Prior to
resection, an abdominopelvic computed tomography (CT)
scan performed to evaluate the distal rectal mass and terminal
ileal inflammation; this indicated wall thickening of the
terminal ileum with several mesenteric lymph nodes in the
right lower quadrant, a 1.5‑cm nodule in the distal rectum with
an enlarged lymph node in the right posterior mesorectum,
and several enlarged nodes along the inferior rectal vessel and
left para‑aortic area (Fig. 3).
The condition of the patient was discussed with a surgeon to
decide the management of multiple enlarged perirectal lymph
nodes. Firstly, a transanal excision of the tumor was performed
to allow pathological diagnosis, which revealed a grade 1
NET (according to the World Health Organization 2010 classification) (1), 1.5x1.2 cm in size and confined to submucosa,
with the following characteristics: Synaptophysin‑positive,
neural cell adhesion molecule (CD56)‑positive, <1 mitosis per
10 high‑power fields (HPF), <1% Ki‑67‑positive cells, and no
lymphovascular invasion (Fig. 4). Immunohistochemically,
the neuroendocrine markers synaptophysin and CD56 were
strong and diffuse throughout the whole tumor, consistent
with a well‑differentiated NET (Fig. 4). Immunohistochemical
staining was performed on 5‑µm‑thick formalin‑fixed
(room temperature for 5 h), paraffin‑embedded tumor tissue
sections using the BenchMark XT automated tissue staining
system (Ventana Medical Systems, Inc., Tucson, AZ, USA)
according to the manufacturer's protocol. The primary antibodies used were synaptophysin (cat. no., 790‑4407; Ventana
Medical Systems, pre‑diluted and ready to use) and CD56 (cat.
no., M7304; clone 123C3; Dako; Agilent Technologies, Inc.,
Santa Clara, CA, USA, dilution 1:100). Each were incubated
with the samples for 30 min at 37˚C. All tissue slides were then
incubated with a horseradish peroxidase‑conjugated secondary
antibody (ultraView Universal DAB Detection kit, Ventana
Medical Systems; cat. no., 760‑500, pre‑diluted and ready to
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Figure 3. Abdominopelvic computed tomography scan indicating multiple enlarged lymph nodes. (A) 1.5‑cm nodule in the distal rectum (arrow). (B) Enlarged
lymph node in the right posterior mesorectum (arrow). (C) Arrows indicate several aggregated enlarged lymph nodes along the inferior rectal vessel. (D) Left
para‑aortic lymph node enlargement (arrow). Wall thickening of the (E) terminal ileum, with (F) several enlarged mesenteric lymph nodes in the right lower
quadrant.

Figure 4. Distal rectal mass obtained through transanal excision. (A) Resected rectal mass, 1.5 cm in size. (B) Histological features showing a
trabecular, ribbon‑like growth pattern of round to oval‑shaped tumor cells. No tumor necrosis was present. Hematoxylin and eosin staining; magnification, x200. (C) Immunohistochemical staining indicating the diffuse expression of synaptophysin throughout the whole tumor (magnification, x100).
(D) Immunohistochemical staining demonstrating the diffuse expression of neural cell adhesion molecule throughout the whole tumor (magnification, x200).

use) for detecting mouse IgG, mouse IgM and rabbit primary
antibodies) for 8 min at 37˚C. All samples were visualized
using light microscopy.
To evaluate the multiple enlarged lymph nodes, Indium‑111
octreotide scanning was performed, which indicated an
increased uptake of multiple enlarged lymph nodes in the
pre‑sacral space at the 4 and 24‑h delayed scans (Fig. 5).
Multiple mesenteric lymph nodes in the right lower quadrant

and left para‑aortic lymph nodes exhibited no significant
abnormal uptake, which suggested a reactive change accompanying acute enteritis.
A laparoscopic low anterior resection was performed,
during which ovoid conglomerated enlarged mesorectal
lymph nodes were identified and removed. The pathological
data suggested that the NET had metastasized to 4 out of the
22 removed lymph nodes. There were no remnant tumors in
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Figure 5. Indium‑111 octreotide scanning indicating the increased uptake of multiple enlarged lymph nodes in the presacral space (arrow). There was no
otherwise definite abnormal increased uptake in the abdomen. ANT, anterior; POST, posterior. The left two panels are images after a 4 h delay, and the right
two panels are after a 24 h delay.

either the resected sigmoid colon or rectal tissues. The final
diagnosis was rectal NET T1bN1M0 [stage IIIb, according
to 2017 American joint Committee on Cancer Staging (12)].
A follow‑up abdominopelvic computed tomography (CT)
scan was performed 6 months after surgery was scheduled
(December, 2017), which indicated no specific abnormal
results. The patient was then scheduled for long‑term
(>5 years) annual surveillance CT. Written informed consent
was obtained from the patient.
Discussion
Rectal NETs are the most common type of gastroenteropancreatic NETs in Asia, accounting for 50% of cases of
gastroenteropancreatic NET (2). The majority of rectal NETs
are asymptomatic, but may present with rectal bleeding or
pain. If a rectal NET is suspected endoscopically (the typical
finding is a yellowish‑colored subepithelial tumor covered by
normal mucosa), a rectal EUS is commonly performed to assess
tumor size, depth of invasion and pararectal lymph nodes (13).
The European Neuroendocrine Tumor Society Consensus
guidelines recommend an imaging study (CT or magnetic
resonance imaging) for tumors >1 cm in size (13), whereas the
North American Neuroendocrine Tumor Society Consensus
guidelines do not routinely recommend cross‑sectional radiographic studies for rectal NETs <2 cm (4,14). If the tumor
size is >2 cm, octreotide scintigraphy, useful for well‑differentiated NETs, or positron emission tomography, useful for
octreotide‑negative tumors (including high‑grade/poorly
differentiated NETs), is recommended (13). Atypical endoscopic features, including semi‑pedunculated morphology of
the tumors, hyperemia, erosion or ulceration, are associated

with tumor size and lymph node metastasis, requiring careful
pretreatment evaluation (15,16).
At present, the only established curative treatment for
rectal NETs is complete resection. Rectal NETs of <1 cm
that are confined within the submucosa may be removed
endoscopically due to the low risk of metastasis (<3%) (13,17).
However, other risk factors (mitotic rate >2 per 10 HPF or
lymphovascular invasion) should also be monitored following
an endoscopic tumor resection, and if any known risk factors
are identified, surgical resection should be considered. If
lesions are >2 cm, the metastatic risk is high (60‑80%), and
radical surgical resection with total mesorectal excision is
required (11,13).
In the case of tumors measuring between 1 and 2 cm in
size, confined within the submucosa and lacking any of the
aforementioned risk factors, there is disagreement about the
optimal treatment modality (endoscopic or transanal resection
vs. radical surgical resection); however, the endoscopic
approach has been prioritized recently due to its minimal
invasiveness and high rate of complete en bloc resection (18).
In the case of the present study, the young male patient
had no known risk factors for metastasis, such as tumor size
(>2 cm), endoscopic morphology involving ulceration, erosion
or hyperemia, old age (>60 years), WHO 2010 classification
grade 3 disease (1), poorly differentiated histology, increased
mitotic index, muscular propria invasion, lymphovascular
invasion, angiogenesis or neural invasion (13,19). However,
significant lymph node metastasis was detected by CT imaging
and octreotide scanning. Similarly, there have been specific
case reports of small rectal carcinoid tumors with multiple
liver or lymph node metastases (20‑22), but those cases exhibited other known high‑risk features despite the small tumor
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size, including central depression, high Ki‑67 labeling index
or lymphovascular invasion.
In summary, the present study described the case of a small
rectal carcinoid tumor (<2 cm) with substantial lymph node
metastasis without any known high‑risk features. Therefore,
the possibility of lymph node or distant metastasis must always
be considered, even in cases of small rectal carcinoid tumors
without any high‑risk features. As highlighted in the present
case, imaging studies, including CT or octreotide scanning,
may be important additional tests for rectal NETs that appear
benign without risk factors.
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